Evidence map›Paper›PMID 26664095›Full record

ArticleIndian journal of psychological medicine

Correlates of Baclofen Effectiveness in Alcohol Dependence.

Lekhansh Shukla, Tulika Shukla, Spandana Bokka, Arun Kandasamy, Vivek Benegal, Pratima Murthy, Prabhat Chand

Abstract read
In one paragraph

Article in Indian journal of psychological medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Alcohol use disorder research in India: An update.Indian journal of psychiatry · 2024
    Review
  2. Article
  3. Brain Functional Magnetic Resonance Imaging Cue-reactivity Can Predict Baclofen Response in Alcohol Use Disorders.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2018
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lekhansh ShuklaCentre for Addiction Medicine, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Tulika ShuklaCentre for Addiction Medicine, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Spandana BokkaCentre for Addiction Medicine, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Arun KandasamyCentre for Addiction Medicine, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Vivek BenegalCentre for Addiction Medicine, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Pratima MurthyCentre for Addiction Medicine, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.
Prabhat ChandCentre for Addiction Medicine, National Institute of Mental Health and Neurosciences, Bangalore, Karnataka, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alcohol dependence is a global concern. Baclofen has shown promise as an anti-craving agent but its efficiency remains to be settled. We reviewed 549 male cases diagnosed with alcohol dependence who received Acamprosate (201) or Baclofen (348). 'Time to first drink' was compared between two groups and multiple regression analysis was done in baclofen group to identify correlates of effectiveness. There was a significant difference in outcome measure between Baclofen (M = 4.44, SD = 3.75) and Acamprosate group (M = 3.73, SD = 2.19); t (547) = 2.45, P = 0.01. Initial regression analysis with six predictor variables (average daily alcohol units, current age, age at onset of dependence, family history, duration of dependence and dose of baclofen in mg/day) showed significant correlation of outcome variable with only two predictor variables - dose of baclofen and average daily intake. Using the hierarchical method it was found that 'dose of baclofen' and 'average alcohol intake' explain a significant amount of variance in 'time to first drink'. [F (1, 345) = 182.8, P < 0.001, R2 = 0.52, R2adjusted = 0.51]. This information can be used to select patients in long term longitudinal studies and may explain variable results seen in clinical trials of baclofen done earlier.

Indexed as

AlcoholanticravingBaclofencorrelateseffectiveness

Identifiers

PMID26664095
PMCPMC4649808

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.